Olaf Welting

The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome

Tamira K. Klooker, Breg Braak, Karin E. Koopman et al. · Gut · 2010 · 406 citations · Full text

Life Sciences, Immunology, Pharmacology +15

Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats

Sara Botschuijver, Guus Roeselers, Evgeni Levin et al. · Gastroenterology · 2017 · 195 citations · Full text

Life Sciences, Immunology, Microbiology +16

Essential role for TRPV1 in stress‐induced (mast cell‐dependent) colonic hypersensitivity in maternally separated rats

René M. van den Wijngaard, Tamira K. Klooker, Olaf Welting et al. · Neurogastroenterology & Motility · 2009 · 114 citations

Life Sciences, Neurobiology, Neuroscience +17

Mucosal Immune Cell Numbers and Visceral Sensitivity in Patients With Irritable Bowel Syndrome: Is There Any Relationship?

Breg Braak, Tamira K. Klooker, Mira M. Wouters et al. · The American Journal of Gastroenterology · 2012 · 93 citations

Life Sciences, Immunology, Pathology +17

A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function

Leonie C.S. De Vries, José Duarte, Manon de Krijger et al. · Inflammatory Bowel Diseases · 2019 · 79 citations · Full text

Medicine, Immunology, Pharmacology +17